木瓜直播

Round-the-clock infusion delivers carbidopa and levodopa pro-drugs

Study may ease fears about potential neurodevelopmental effects of fetal COVID exposure

Phase III trial met primary endpoint at 6 months

Topline phase III data show inebilizumab met primary endpoint

News and commentary from the world of neurology and neuroscience

Nearly 6% of lecanemab may be discarded each year

Feeling lonely also linked with cognitive impairment that's not dementia, meta-analysis shows

10% of patients in trials leading to eli-cel's approval developed MDS or AML

Bladder, brain, and cervical cancer risks were higher in people with MS

Fewer cerebral ischemic events also observed with care teams quicker to give blood

Annual evaluation tied to timelier mild cognitive impairment diagnoses

News and commentary from the world of neurology and neuroscience

No benefit for brain fog or fatigue, but higher doses may have promise

News and commentary from the world of neurology and neuroscience